Production & Manufacturing
Manufacturing

Manufacturing News

View news from other Pharmaceutical sectors:
61-75 of 2321 results
Regeneron Pharmaceuticals to invest $100m in Irish facility
By PBR Staff Writer
US-based Regeneron Pharmaceuticals will invest an additional $100m to expand its bioprocessing campus in Limerick, Ireland, to increase its drug substance production capacity.
Production & Manufacturing > Manufacturing > News
Clinigen acquires Japanese unlicensed medicines supplier
Clinigen Group has acquired International Medical Management (IMMC), Japan’s largest supplier of unlicensed medicines, for an undisclosed sum.
Production & Manufacturing > Manufacturing > News
Teva seeks FDA approval for migraine drug fremanezumab
By PBR Staff Writer
Israel-based Teva Pharmaceutical Industries is seeking approval of its migraine drug fremanezumab in the US having filed a Biologics License Application (BLA) with the US Food and Drug Administration (FDA).
Production & Manufacturing > Manufacturing > News
Amneal to acquire Impax to expand generics business in US
By PBR Staff Writer
Amneal Pharmaceuticals has agreed to buy Impax Laboratories in an all-stock deal to create a diversified pharmaceutical firm that is expected to become the fifth largest generics business in the US.
Production & Manufacturing > Manufacturing > News
Lupin buys Symbiomix to expand women’s health specialty business
By PBR Staff Writer
Mumbai-based Lupin’s US subsidiary has acquired Symbiomix Therapeutics for $150m in an all-cash deal to expand its branded women’s health specialty business.
Production & Manufacturing > Manufacturing > News
Sanofi to invest €170m for expansion of French vaccine manufacturing facility
By PBR Staff Writer
Sanofi is set to invest around €170m to expand its vaccine manufacturing facility in Val de Reuil, France.
Production & Manufacturing > Manufacturing > News
Merck halts development of MK-3682B and MK-3682C programs
Merck announced its strategic decision to discontinue the development of the investigational combination regimens MK-3682B (grazoprevir/ruzasvir/ uprifosbuvir) and MK-3682C (ruzasvir/uprifosbuvir) for the treatment of chronic hepatitis C virus (HCV) infection.
Production & Manufacturing > Manufacturing > News
Roche's Perjeta regimen secures FDA priority review in breast cancer
The US Food and Drug Administration (FDA) has granted priority review for Roche’s Perjeta in combination with Herceptin and chemotherapy to treat HER2-positive early breast cancer after surgery.
Production & Manufacturing > Manufacturing > News
Catalent to acquire Indiana-based CDMO Cook Pharmica for $950m
By PBR Staff Writer
Catalent has agreed to acquire Indiana-based contract development and manufacturing organization (CDMO) Cook Pharmica for $950m to consolidate its position in the bio-pharma sector.
Production & Manufacturing > Manufacturing > News
CHMP recommends GSK, Innoviva’s single inhaler triple therapy for COPD
By PBR Staff Writer
GlaxoSmithKline (GSK) and Innoviva announced that a committee of the European Medicines Agency (EMA) has adopted positive opinion for fluticasone furoate/ umeclidinium/vilanterol (FF/UMEC/VI) in treating chronic obstructive pulmonary disease (COPD) in adults.
Production & Manufacturing > Manufacturing > News
Eli Lilly to cut 3,500 jobs globally
By PBR Staff Writer
Eli Lilly plans to cut its overall workforce by 3,500 and trim its global operations to improve its cost structure for facilitating development of new medicines.
Production & Manufacturing > Manufacturing > News
Bioverativ, Bicycle Therapeutics to develop therapies for hemophilia and sickle cell disease
Bioverativ and Bicycle Therapeutics have announced a research collaboration focused on the discovery, development and commercialization of innovative therapies for hemophilia and sickle cell disease.
Production & Manufacturing > Manufacturing > News
PATH boosts leadership in developing and introducing urgently needed vaccines
PATH has received a $120m grant from the Bill & Melinda Gates Foundation to further strengthen its PATH Center for Vaccine Innovation and Access (CVIA), which works across every stage of vaccine research, development, and introduction for diseases in low-resource settings.
Production & Manufacturing > Manufacturing > News
TiGenix obtains commercial production license for expanded manufacturing facility
TiGenix has obtained a license for the commercial production of expanded adipose-derived stem cells (eASCs) at its expanded manufacturing facility in Madrid.
Production & Manufacturing > Manufacturing > News
Therapure Biopharma to sell CDMO business to 3SBio
By PBR Staff Writer
Canada-based Therapure Biopharma has agreed to divest its contract development and manufacturing (CDMO) business to a joint venture between Chinese biotechnology company 3SBio and CPE Funds for $290m.
Production & Manufacturing > Manufacturing > News
61-75 of 2321 results